# pathway_nodes

date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: SECUKINUMAB
cost_pp_pa: 4900.75
first_seen: 2019-07-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-07-02
last_seen_parent: 2025-09-26
average_administered: [11.777777777777779, 5.222222222222222, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.8 times with a 7.3 weekly interval (86.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 5.2 times with a 14.3 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 3161.39
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-30
average_administered: [12.343283582089553, 8.149253731343284, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12.3 times with a 12.1 weekly interval (149.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 8.1 times with a 7.1 weekly interval (58.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2244.7
first_seen: 2019-04-22T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-23
average_administered: [16.571428571428573, 1.5714285714285714, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.6 times with a 13.6 weekly interval (225.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 1.6 times with a 3.0 weekly interval (5.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 7046.37
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [8.6, 16.466666666666665, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB - VEDOLIZUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.6 times with a 5.4 weekly interval (47.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 16.5 times with a 7.6 weekly interval (125.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 3810.0
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-04
average_administered: [13.04, 12.48, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13.0 times with a 9.9 weekly interval (128.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12.5 times with a 14.9 weekly interval (186.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3195.55
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [7.90625, 15.109375, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7.9 times with a 35.1 weekly interval (278.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.1 times with a 6.6 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 8579.92
first_seen: 2020-05-27T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2020-05-27
last_seen_parent: 2025-12-17
average_administered: [8.142857142857142, 14.428571428571429, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.1 times with a 6.6 weekly interval (53.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 14.4 times with a 6.4 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 3511.34
first_seen: 2019-05-08T00:00:00
last_seen: 2025-10-15T00:00:00
first_seen_parent: 2019-04-21
last_seen_parent: 2025-12-31
average_administered: [23.8, 4.4, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.8 times with a 12.7 weekly interval (303.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 4.4 times with a 18.0 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2669.66
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [18.40740740740741, 6.2407407407407405, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18.4 times with a 11.3 weekly interval (208.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.2 times with a 5.1 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: DEXAMETHASONE
cost_pp_pa: 3586.51
first_seen: 2019-06-13T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2019-06-13
last_seen_parent: 2025-12-30
average_administered: [15.0, 4.25, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15.0 times with a 9.7 weekly interval (146.0 weeks total treatment length)<br><b>DEXAMETHASONE</b><br>On average given 4.2 times with a 26.6 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3979.96
first_seen: 2019-06-07T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-21
average_administered: [21.085714285714285, 11.885714285714286, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.1 times with a 7.6 weekly interval (160.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 11.9 times with a 7.7 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2594.82
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [14.916666666666666, 8.75, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14.9 times with a 10.4 weekly interval (155.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 8.8 times with a 8.0 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 4836.9
first_seen: 2019-09-06T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-06-22
last_seen_parent: 2025-12-21
average_administered: [8.0, 11.2, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.0 times with a 11.6 weekly interval (93.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 11.2 times with a 8.6 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4081.84
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [7.303571428571429, 10.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7.3 times with a 14.0 weekly interval (102.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 10.5 times with a 13.6 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2864.63
first_seen: 2023-01-24T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-09-26
average_administered: [3.8, 4.2, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB|GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB - GALCANEZUMAB

average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 3.8 times with a 7.4 weekly interval (28.0 weeks total treatment length)<br><b>GALCANEZUMAB</b><br>On average given 4.2 times with a 7.0 weekly interval (29.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 4011.81
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-30
average_administered: [10.645569620253164, 16.696202531645568, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 10.6 times with a 15.7 weekly interval (167.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 16.7 times with a 9.4 weekly interval (157.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4315.87
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [20.971153846153847, 13.01923076923077, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21.0 times with a 7.6 weekly interval (159.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 13.0 times with a 7.4 weekly interval (97.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: RANIBIZUMAB
cost_pp_pa: 2208.0
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-27
average_administered: [15.636363636363637, 4.909090909090909, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15.6 times with a 9.9 weekly interval (154.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 4.9 times with a 8.0 weekly interval (39.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: RANIBIZUMAB
cost_pp_pa: 2626.53
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-11-21
average_administered: [19.7, 7.8, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - RANIBIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19.7 times with a 9.1 weekly interval (180.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 7.8 times with a 7.7 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: AFLIBERCEPT
cost_pp_pa: 3484.49
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [16.94, 17.26, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 16.9 times with a 15.6 weekly interval (263.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 17.3 times with a 14.1 weekly interval (245.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3078.23
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-31
average_administered: [8.17674418604651, 15.61860465116279, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8.2 times with a 28.9 weekly interval (237.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 15.6 times with a 5.7 weekly interval (89.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 3116.18
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [20.0, 9.3125, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.0 times with a 10.1 weekly interval (203.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 9.3 times with a 7.4 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 2820.33
first_seen: 2019-04-19T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-09
last_seen_parent: 2025-12-30
average_administered: [8.428571428571429, 15.714285714285714, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - INFLIXIMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.4 times with a 6.6 weekly interval (55.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 15.7 times with a 7.7 weekly interval (121.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: IXEKIZUMAB
cost_pp_pa: 4024.45
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-18
average_administered: [10.0, 11.2, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - IXEKIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.0 times with a 10.1 weekly interval (101.0 weeks total treatment length)<br><b>IXEKIZUMAB</b><br>On average given 11.2 times with a 9.1 weekly interval (102.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: VEDOLIZUMAB
cost_pp_pa: 7135.71
first_seen: 2020-05-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-05-01
last_seen_parent: 2025-12-31
average_administered: [10.833333333333334, 9.333333333333334, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB - VEDOLIZUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10.8 times with a 7.1 weekly interval (77.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9.3 times with a 5.0 weekly interval (46.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: SECUKINUMAB
cost_pp_pa: 5510.44
first_seen: 2019-04-09T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-29
average_administered: [7.769230769230769, 18.692307692307693, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB - SECUKINUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.8 times with a 7.7 weekly interval (60.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 18.7 times with a 9.1 weekly interval (171.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 5134.4
first_seen: 2019-07-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-07-10
last_seen_parent: 2025-12-30
average_administered: [9.428571428571429, 18.285714285714285, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.4 times with a 16.7 weekly interval (157.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 18.3 times with a 10.0 weekly interval (183.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 3089.62
first_seen: 2021-06-12T00:00:00
last_seen: 2025-06-24T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-15
average_administered: [9.0, 24.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - TOCILIZUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.0 times with a 8.9 weekly interval (80.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 24.0 times with a 1.7 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: UPADACITINIB
cost_pp_pa: 2243.13
first_seen: 2019-04-23T00:00:00
last_seen: 2025-11-24T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-11-24
average_administered: [14.5, 12.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - UPADACITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.5 times with a 7.9 weekly interval (114.0 weeks total treatment length)<br><b>UPADACITINIB</b><br>On average given 12.0 times with a 6.7 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: BARICITINIB
cost_pp_pa: 4033.23
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [2.8, 15.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - BARICITINIB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.8 times with a 7.3 weekly interval (20.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 15.0 times with a 13.0 weekly interval (195.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 4686.12
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-31
average_administered: [11.25, 10.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.2 times with a 6.6 weekly interval (74.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 10.8 times with a 4.6 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 2088.57
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [9.847826086956522, 5.826086956521739, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.8 times with a 7.3 weekly interval (71.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 5.8 times with a 15.0 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2993.97
first_seen: 2019-06-08T00:00:00
last_seen: 2025-10-23T00:00:00
first_seen_parent: 2019-06-08
last_seen_parent: 2025-12-29
average_administered: [30.0, 13.5, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB - ADALIMUMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 30.0 times with a 2.6 weekly interval (77.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 13.5 times with a 18.4 weekly interval (249.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ABATACEPT
cost_pp_pa: 3914.69
first_seen: 2019-04-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [22.916666666666668, 5.25, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB|ABATACEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB - ABATACEPT

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22.9 times with a 17.1 weekly interval (393.0 weeks total treatment length)<br><b>ABATACEPT</b><br>On average given 5.2 times with a 42.0 weekly interval (218.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 5029.73
first_seen: 2019-04-11T00:00:00
last_seen: 2025-08-05T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-11-24
average_administered: [6.166666666666667, 55.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB - TOCILIZUMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6.2 times with a 19.9 weekly interval (123.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 55.0 times with a 2.7 weekly interval (149.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 11201.04
first_seen: 2021-01-19T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-01-19
last_seen_parent: 2025-12-31
average_administered: [3.2, 19.2, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.2 times with a 7.7 weekly interval (25.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 19.2 times with a 6.1 weekly interval (118.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 4150.99
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [14.833333333333334, 11.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14.8 times with a 19.4 weekly interval (288.0 weeks total treatment length)<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 11.0 times with a 12.1 weekly interval (134.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 6594.07
first_seen: 2019-04-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [7.0, 8.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB|RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.0 times with a 7.3 weekly interval (51.0 weeks total treatment length)<br><b>RISANKIZUMAB</b><br>On average given 8.0 times with a 13.3 weekly interval (106.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7258.8
first_seen: 2021-12-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-30
average_administered: [11.25, 2.5, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.2 times with a 12.0 weekly interval (134.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 2.5 times with a 6.4 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 3828.48
first_seen: 2021-04-14T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2021-04-14
last_seen_parent: 2025-11-26
average_administered: [19.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx) - OMALIZUMAB

average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 19.3 times with a 3.4 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2162.06
first_seen: 2019-06-06T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-11-25
average_administered: [10.38888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.4 times with a 18.7 weekly interval (195.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4998.39
first_seen: 2022-09-01T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2022-09-01
last_seen_parent: 2025-11-27
average_administered: [20.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20.1 times with a 6.1 weekly interval (123.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1324.38
first_seen: 2019-06-24T00:00:00
last_seen: 2025-10-16T00:00:00
first_seen_parent: 2019-06-24
last_seen_parent: 2025-10-16
average_administered: [17.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17.6 times with a 9.4 weekly interval (166.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4075.46
first_seen: 2019-06-27T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-11-27
average_administered: [16.0625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16.1 times with a 6.4 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2741.55
first_seen: 2022-12-02T00:00:00
last_seen: 2025-10-22T00:00:00
first_seen_parent: 2021-02-22
last_seen_parent: 2025-11-10
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.8 times with a 9.7 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3578.18
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-11
last_seen_parent: 2025-12-31
average_administered: [10.711538461538462, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.7 times with a 10.0 weekly interval (107.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4113.89
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [26.642857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 26.6 times with a 6.7 weekly interval (179.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 22030.95
first_seen: 2024-05-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-23
last_seen_parent: 2025-12-31
average_administered: [6.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 6.5 times with a 4.4 weekly interval (29.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: ADALIMUMAB
cost_pp_pa: 2271.6
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [27.535353535353536, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27.5 times with a 8.3 weekly interval (228.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: TOFACITINIB
cost_pp_pa: 5031.32
first_seen: 2019-11-15T00:00:00
last_seen: 2025-12-05T00:00:00
first_seen_parent: 2019-11-15
last_seen_parent: 2025-12-05
average_administered: [25.818181818181817, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: TOFACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - TOFACITINIB

average_spacing:
<br><b>TOFACITINIB</b><br>On average given 25.8 times with a 7.3 weekly interval (188.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: UPADACITINIB
cost_pp_pa: 8548.05
first_seen: 2023-09-15T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2023-09-15
last_seen_parent: 2025-12-12
average_administered: [7.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 7.4 times with a 7.4 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ADALIMUMAB
cost_pp_pa: 1798.45
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [25.225688073394494, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25.2 times with a 8.4 weekly interval (212.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: BARICITINIB
cost_pp_pa: 4681.14
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [21.526315789473685, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - BARICITINIB

average_spacing:
<br><b>BARICITINIB</b><br>On average given 21.5 times with a 12.9 weekly interval (276.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 2614.28
first_seen: 2022-11-09T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-11-09
last_seen_parent: 2025-12-30
average_administered: [8.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - FILGOTINIB

average_spacing:
<br><b>FILGOTINIB</b><br>On average given 8.5 times with a 7.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 1818.23
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [8.858695652173912, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.9 times with a 24.7 weekly interval (220.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: TOCILIZUMAB
cost_pp_pa: 7747.79
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [88.89473684210526, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 88.9 times with a 4.6 weekly interval (406.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2726.79
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [16.234126984126984, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.2 times with a 11.6 weekly interval (187.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 351.94
first_seen: 2021-03-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-03-16
last_seen_parent: 2025-12-30
average_administered: [3.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.1 times with a 19.0 weekly interval (59.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 2333.78
first_seen: 2019-08-22T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2019-08-22
last_seen_parent: 2025-11-20
average_administered: [4.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 4.5 times with a 31.6 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx) - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 22486.83
first_seen: 2024-07-19T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-07-19
last_seen_parent: 2025-12-11
average_administered: [10.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 10.7 times with a 3.1 weekly interval (34.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx) - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7726.23
first_seen: 2024-10-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-10-29
last_seen_parent: 2025-12-29
average_administered: [9.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9.4 times with a 1.9 weekly interval (17.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx) - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 2346.37
first_seen: 2024-09-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-04-15
last_seen_parent: 2025-12-18
average_administered: [5.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 5.7 times with a 2.4 weekly interval (14.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2389.56
first_seen: 2021-04-26T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-04-26
last_seen_parent: 2025-12-30
average_administered: [18.272727272727273, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 18.3 times with a 9.4 weekly interval (173.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: OBINUTUZUMAB
cost_pp_pa: 38245.98
first_seen: 2024-12-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-09-02
last_seen_parent: 2025-12-31
average_administered: [7.9375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - OBINUTUZUMAB

average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 7.9 times with a 1.9 weekly interval (15.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: RITUXIMAB
cost_pp_pa: 5209.44
first_seen: 2020-11-27T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2020-11-27
last_seen_parent: 2025-12-31
average_administered: [11.82638888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.8 times with a 2.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis
labels: TOCILIZUMAB
cost_pp_pa: 11174.17
first_seen: 2022-12-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-12
last_seen_parent: 2025-12-29
average_administered: [9.227272727272727, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: giant cell arteritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9.2 times with a 4.4 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 28082.0
first_seen: 2025-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-26
last_seen_parent: 2025-12-31
average_administered: [4.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma - ATEZOLIZUMAB

average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 4.8 times with a 3.3 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: TOCILIZUMAB
cost_pp_pa: 5552.51
first_seen: 2019-04-30T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-04-30
last_seen_parent: 2025-12-15
average_administered: [35.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: juvenile idiopathic arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
parents:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - juvenile idiopathic arthritis

ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - juvenile idiopathic arthritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 35.0 times with a 8.6 weekly interval (300.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: AFLIBERCEPT
cost_pp_pa: 2354.15
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-24
average_administered: [20.686274509803923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.7 times with a 16.6 weekly interval (343.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ETANERCEPT
cost_pp_pa: 3414.65
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-29
average_administered: [31.13888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ETANERCEPT

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 31.1 times with a 8.6 weekly interval (267.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: GOLIMUMAB
cost_pp_pa: 7965.63
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-30
average_administered: [31.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - GOLIMUMAB

average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 31.0 times with a 9.1 weekly interval (283.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: UPADACITINIB
cost_pp_pa: 4427.69
first_seen: 2022-11-09T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2022-11-09
last_seen_parent: 2025-12-18
average_administered: [11.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 11.7 times with a 5.9 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 3005.62
first_seen: 2022-10-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2022-10-11
last_seen_parent: 2025-12-31
average_administered: [3.8333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 3.8 times with a 28.7 weekly interval (109.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 4536.4
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-18
last_seen_parent: 2025-12-31
average_administered: [6.615384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.6 times with a 7.1 weekly interval (47.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: IXEKIZUMAB
cost_pp_pa: 9697.5
first_seen: 2020-03-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-22
average_administered: [19.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - IXEKIZUMAB

average_spacing:
<br><b>IXEKIZUMAB</b><br>On average given 19.5 times with a 8.0 weekly interval (156.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: SECUKINUMAB
cost_pp_pa: 7918.41
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [21.03846153846154, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21.0 times with a 9.9 weekly interval (207.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer
labels: DOCETAXEL
cost_pp_pa: 631.88
first_seen: 2025-01-13T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-01-13
last_seen_parent: 2025-12-23
average_administered: [3.8333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer - DOCETAXEL

average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.8 times with a 3.0 weekly interval (11.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ADALIMUMAB
cost_pp_pa: 1980.49
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [27.40963855421687, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27.4 times with a 9.6 weekly interval (262.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1712.84
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-30
average_administered: [31.877551020408163, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 31.9 times with a 8.6 weekly interval (273.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: ADALIMUMAB
cost_pp_pa: 2162.92
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [25.257142857142856, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25.3 times with a 8.7 weekly interval (220.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: APREMILAST
cost_pp_pa: 6011.23
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-22
average_administered: [13.842105263157896, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 13.8 times with a 11.9 weekly interval (164.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 10081.38
first_seen: 2019-04-19T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-04
average_administered: [20.09090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 20.1 times with a 10.7 weekly interval (215.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: INFLIXIMAB
cost_pp_pa: 3435.67
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [29.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29.0 times with a 7.1 weekly interval (207.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
labels: BEVACIZUMAB
cost_pp_pa: 456.41
first_seen: 2022-03-09T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2022-03-09
last_seen_parent: 2025-12-15
average_administered: [5.2727272727272725, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.3 times with a 21.9 weekly interval (116.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 704.07
first_seen: 2025-04-25T00:00:00
last_seen: 2025-11-13T00:00:00
first_seen_parent: 2025-04-25
last_seen_parent: 2025-11-13
average_administered: [2.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 2.2 times with a 2.6 weekly interval (6.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 30240.48
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [17.627906976744185, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 17.6 times with a 4.3 weekly interval (75.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 5546.07
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-31
average_administered: [10.027397260273972, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.0 times with a 2.7 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 3796.24
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [17.181818181818183, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17.2 times with a 6.4 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: VEDOLIZUMAB
cost_pp_pa: 11702.4
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [26.972602739726028, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27.0 times with a 7.3 weekly interval (197.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 4540.34
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-23
average_administered: [29.714285714285715, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29.7 times with a 9.4 weekly interval (280.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3776.3
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [25.692307692307693, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 25.7 times with a 5.7 weekly interval (147.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3853.39
first_seen: 2023-05-26T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2023-05-26
last_seen_parent: 2025-12-22
average_administered: [5.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.7 times with a 8.6 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: FARICIMAB
cost_pp_pa: 5465.42
first_seen: 2024-06-05T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-06-05
last_seen_parent: 2025-12-11
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB

average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.0 times with a 3.3 weekly interval (13.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 2739.82
first_seen: 2021-05-04T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-05-04
last_seen_parent: 2025-12-23
average_administered: [13.185185185185185, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 13.2 times with a 14.3 weekly interval (189.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - multiple sclerosis
labels: DIMETHYL FUMARATE
cost_pp_pa: 2291.71
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [6.918918918918919, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: multiple sclerosis
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - multiple sclerosis - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 6.9 times with a 11.4 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
labels: BEVACIZUMAB
cost_pp_pa: 577.66
first_seen: 2023-01-24T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-12-19
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6.0 times with a 10.4 weekly interval (63.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2269.59
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-31
average_administered: [12.270440251572326, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12.3 times with a 9.9 weekly interval (121.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 5162.1
first_seen: 2019-07-31T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-17
last_seen_parent: 2025-12-30
average_administered: [20.571428571428573, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20.6 times with a 11.7 weekly interval (241.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4731.57
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-31
average_administered: [7.918367346938775, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.9 times with a 11.7 weekly interval (93.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: IMMUNOGLOBULIN
cost_pp_pa: 36147.2
first_seen: 2024-04-04T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-09-24
average_administered: [15.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 15.8 times with a 2.7 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2379.79
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-24
average_administered: [28.1123595505618, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28.1 times with a 7.3 weekly interval (205.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: IXEKIZUMAB
cost_pp_pa: 9248.13
first_seen: 2022-09-02T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2022-09-02
last_seen_parent: 2025-11-20
average_administered: [17.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: IXEKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - IXEKIZUMAB

average_spacing:
<br><b>IXEKIZUMAB</b><br>On average given 17.0 times with a 7.7 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 2226.95
first_seen: 2019-05-02T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2019-05-02
last_seen_parent: 2025-12-18
average_administered: [6.921568627450981, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6.9 times with a 25.6 weekly interval (176.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: SECUKINUMAB
cost_pp_pa: 5097.15
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-29
average_administered: [26.655172413793103, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26.7 times with a 10.1 weekly interval (271.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: TOCILIZUMAB
cost_pp_pa: 6771.25
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [51.642857142857146, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 51.6 times with a 6.4 weekly interval (332.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 12265.72
first_seen: 2019-04-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-05
last_seen_parent: 2025-12-31
average_administered: [19.454545454545453, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19.5 times with a 6.4 weekly interval (125.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2771.87
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [17.522727272727273, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17.5 times with a 11.6 weekly interval (202.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 7951.14
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-22
average_administered: [26.833333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 26.8 times with a 9.1 weekly interval (245.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 3677.57
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [36.133720930232556, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 36.1 times with a 8.7 weekly interval (315.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1818.57
first_seen: 2025-01-06T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-01-06
last_seen_parent: 2025-12-19
average_administered: [4.35, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: breast cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.3 times with a 2.1 weekly interval (9.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5247.62
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-31
average_administered: [7.4411764705882355, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.4 times with a 3.0 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4578.23
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [17.32758620689655, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17.3 times with a 5.4 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2872.83
first_seen: 2019-04-02T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [10.76061776061776, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10.8 times with a 13.7 weekly interval (148.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2531.0
first_seen: 2019-04-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [11.74468085106383, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 11.7 times with a 11.0 weekly interval (129.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4893.32
first_seen: 2019-07-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-07-11
last_seen_parent: 2025-12-31
average_administered: [6.488372093023256, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.5 times with a 10.6 weekly interval (69.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2684.64
first_seen: 2021-09-02T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2021-09-02
last_seen_parent: 2025-12-19
average_administered: [9.7, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.7 times with a 9.0 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: IMMUNOGLOBULIN
cost_pp_pa: 56863.04
first_seen: 2024-04-03T00:00:00
last_seen: 2025-09-24T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-10-30
average_administered: [17.210526315789473, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 17.2 times with a 3.3 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: AFLIBERCEPT
cost_pp_pa: 3025.51
first_seen: 2019-04-22T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-04-22
last_seen_parent: 2025-12-24
average_administered: [18.058823529411764, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18.1 times with a 10.0 weekly interval (181.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 245.28
first_seen: 2021-02-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2021-02-01
last_seen_parent: 2025-12-31
average_administered: [2.8181818181818183, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.8 times with a 13.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2421.64
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [12.119565217391305, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12.1 times with a 9.9 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2704.67
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-31
average_administered: [16.92156862745098, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16.9 times with a 11.4 weekly interval (193.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3835.84
first_seen: 2023-11-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2023-11-03
last_seen_parent: 2025-12-31
average_administered: [5.689655172413793, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.7 times with a 6.3 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 2851.18
first_seen: 2022-01-17T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2022-01-17
last_seen_parent: 2025-12-19
average_administered: [17.11111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: migraine
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 17.1 times with a 8.1 weekly interval (139.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ovarian cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 7867.63
first_seen: 2024-11-25T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-11-25
last_seen_parent: 2025-12-31
average_administered: [8.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 8.7 times with a 2.7 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: FREMANEZUMAB
cost_pp_pa: 2813.61
first_seen: 2021-06-01T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2021-06-01
last_seen_parent: 2025-12-23
average_administered: [15.03448275862069, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - FREMANEZUMAB

average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 15.0 times with a 13.6 weekly interval (204.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1937.18
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [26.31, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26.3 times with a 9.1 weekly interval (240.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4439.19
first_seen: 2024-01-25T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-01-25
last_seen_parent: 2025-12-31
average_administered: [5.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.7 times with a 5.6 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5405.67
first_seen: 2024-06-20T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-20
last_seen_parent: 2025-12-31
average_administered: [7.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.9 times with a 3.4 weekly interval (27.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ankylosing spondylitis
labels: ADALIMUMAB
cost_pp_pa: 1689.29
first_seen: 2019-04-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-07
last_seen_parent: 2025-12-29
average_administered: [35.523809523809526, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ankylosing spondylitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ankylosing spondylitis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 35.5 times with a 9.3 weekly interval (330.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3692.51
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [29.784246575342465, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29.8 times with a 7.7 weekly interval (230.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7351.21
first_seen: 2019-06-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-17
last_seen_parent: 2025-12-30
average_administered: [12.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 12.0 times with a 11.9 weekly interval (142.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4320.21
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-11
average_administered: [30.692307692307693, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 30.7 times with a 4.6 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
labels: DUPILUMAB
cost_pp_pa: 7835.79
first_seen: 2022-08-12T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2022-08-12
last_seen_parent: 2025-11-25
average_administered: [7.071428571428571, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB

average_spacing:
<br><b>DUPILUMAB</b><br>On average given 7.1 times with a 9.3 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2207.94
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-31
average_administered: [9.704761904761904, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.7 times with a 10.3 weekly interval (100.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: 4056.75
first_seen: 2019-05-17T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-05-17
last_seen_parent: 2025-12-24
average_administered: [20.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: BARICITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20.3 times with a 13.4 weekly interval (273.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1637.14
first_seen: 2022-12-05T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2022-12-05
last_seen_parent: 2025-12-29
average_administered: [5.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.8 times with a 10.6 weekly interval (61.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 6667.91
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-02
average_administered: [42.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 42.2 times with a 8.0 weekly interval (338.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8069.85
first_seen: 2019-04-08T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-11-20
average_administered: [20.266666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 20.3 times with a 12.7 weekly interval (258.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1481.79
first_seen: 2024-07-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-07-29
last_seen_parent: 2025-12-29
average_administered: [5.478260869565218, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 5.5 times with a 2.6 weekly interval (14.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 11798.93
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-31
average_administered: [22.333333333333332, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 22.3 times with a 7.7 weekly interval (172.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: DIMETHYL FUMARATE
cost_pp_pa: 2078.63
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-29
average_administered: [7.095238095238095, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: DIMETHYL FUMARATE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - DIMETHYL FUMARATE

average_spacing:
<br><b>DIMETHYL FUMARATE</b><br>On average given 7.1 times with a 12.3 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2930.36
first_seen: 2020-01-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2020-01-07
last_seen_parent: 2025-12-31
average_administered: [9.423076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.4 times with a 10.0 weekly interval (94.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2524.83
first_seen: 2019-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-02
last_seen_parent: 2025-12-30
average_administered: [34.96491228070175, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 35.0 times with a 8.3 weekly interval (290.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 71505.91
first_seen: 2024-04-10T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-11
average_administered: [9.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 9.5 times with a 9.3 weekly interval (88.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 4612.51
first_seen: 2019-04-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-04
last_seen_parent: 2025-12-30
average_administered: [20.303030303030305, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20.3 times with a 5.9 weekly interval (119.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: RISANKIZUMAB
cost_pp_pa: 18473.04
first_seen: 2024-05-02T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-02
last_seen_parent: 2025-12-31
average_administered: [6.481481481481482, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB

average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 6.5 times with a 6.1 weekly interval (40.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: UPADACITINIB
cost_pp_pa: 6790.18
first_seen: 2024-11-28T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-11-28
last_seen_parent: 2025-12-09
average_administered: [4.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 4.5 times with a 4.9 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx)
labels: OCTREOTIDE
cost_pp_pa: 5720.25
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-11
average_administered: [11.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY (no GP dx)
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx) - OCTREOTIDE

average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 11.1 times with a 4.6 weekly interval (51.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 3826.61
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-30
average_administered: [25.86111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - OMALIZUMAB

average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 25.9 times with a 5.4 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: SECUKINUMAB
cost_pp_pa: 9012.32
first_seen: 2019-04-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-17
last_seen_parent: 2025-12-30
average_administered: [11.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11.7 times with a 12.9 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 7603.75
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-31
average_administered: [9.419354838709678, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9.4 times with a 1.9 weekly interval (17.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2510.79
first_seen: 2019-04-06T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2019-04-06
last_seen_parent: 2025-12-16
average_administered: [16.507042253521128, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16.5 times with a 9.6 weekly interval (158.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: APREMILAST
cost_pp_pa: 4196.93
first_seen: 2019-04-16T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-12
average_administered: [12.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - APREMILAST

average_spacing:
<br><b>APREMILAST</b><br>On average given 12.5 times with a 11.1 weekly interval (139.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2899.97
first_seen: 2020-06-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-31
average_administered: [13.717948717948717, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.7 times with a 8.3 weekly interval (114.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 6615.56
first_seen: 2019-04-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-10
last_seen_parent: 2025-12-30
average_administered: [13.526315789473685, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13.5 times with a 9.4 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1843.96
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [27.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27.6 times with a 9.3 weekly interval (256.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ALIROCUMAB
cost_pp_pa: 2245.81
first_seen: 2022-10-21T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-10-21
last_seen_parent: 2025-12-30
average_administered: [14.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 14.0 times with a 7.1 weekly interval (100.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: EVOLOCUMAB
cost_pp_pa: 1861.19
first_seen: 2019-04-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-04-23
last_seen_parent: 2025-12-30
average_administered: [49.041666666666664, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 49.0 times with a 4.9 weekly interval (238.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 31083.95
first_seen: 2024-04-09T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-04-09
last_seen_parent: 2025-12-22
average_administered: [17.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 17.3 times with a 4.3 weekly interval (74.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 21342.11
first_seen: 2024-04-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-09-26
average_administered: [18.025641025641026, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 18.0 times with a 2.6 weekly interval (46.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1994.64
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [22.11801242236025, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.1 times with a 9.4 weekly interval (208.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1838.0
first_seen: 2019-06-08T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-08
last_seen_parent: 2025-12-31
average_administered: [13.08695652173913, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13.1 times with a 17.7 weekly interval (232.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: 8804.98
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-31
average_administered: [156.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 156.9 times with a 3.1 weekly interval (493.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 3357.28
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [23.724137931034484, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23.7 times with a 8.7 weekly interval (207.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - FILGOTINIB
labels: FILGOTINIB
cost_pp_pa: 2948.38
first_seen: 2021-12-10T00:00:00
last_seen: 2025-09-21T00:00:00
first_seen_parent: 2021-10-25
last_seen_parent: 2025-12-22
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 6.8 times with a 18.7 weekly interval (127.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - GOLIMUMAB
labels: GOLIMUMAB
cost_pp_pa: 7600.38
first_seen: 2019-06-05T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-09-26
average_administered: [47.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: GOLIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GOLIMUMAB</b><br>On average given 47.2 times with a 6.6 weekly interval (310.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3504.21
first_seen: 2019-04-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-01
last_seen_parent: 2025-12-29
average_administered: [31.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 31.8 times with a 11.3 weekly interval (359.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4625.67
first_seen: 2024-10-16T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-10-16
last_seen_parent: 2025-12-17
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.2 times with a 4.7 weekly interval (20.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 302.92
first_seen: 2024-08-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-08-02
last_seen_parent: 2025-12-29
average_administered: [7.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 7.4 times with a 2.1 weekly interval (16.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1682.6
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-29
average_administered: [16.153846153846153, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16.2 times with a 11.3 weekly interval (183.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4539.73
first_seen: 2019-06-14T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-14
last_seen_parent: 2025-12-24
average_administered: [18.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18.6 times with a 6.9 weekly interval (128.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2265.95
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-29
average_administered: [13.72340425531915, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13.7 times with a 10.3 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 9347.27
first_seen: 2019-07-15T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2019-07-15
last_seen_parent: 2025-11-26
average_administered: [32.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 32.2 times with a 9.4 weekly interval (304.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: 8336.15
first_seen: 2021-05-24T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-10-08
average_administered: [14.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14.3 times with a 11.7 weekly interval (168.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 8065.8
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-24
average_administered: [23.846153846153847, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23.8 times with a 12.9 weekly interval (306.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3949.28
first_seen: 2019-04-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-12
last_seen_parent: 2025-12-29
average_administered: [19.615384615384617, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19.6 times with a 5.7 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2420.89
first_seen: 2019-05-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-05-03
last_seen_parent: 2025-12-30
average_administered: [9.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 9.0 times with a 11.0 weekly interval (99.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3440.84
first_seen: 2023-04-12T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2023-04-12
last_seen_parent: 2025-12-17
average_administered: [7.416666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 7.4 times with a 11.3 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3017.85
first_seen: 2019-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-04-03
last_seen_parent: 2025-12-31
average_administered: [13.153846153846153, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13.2 times with a 10.3 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 8179.21
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-24
average_administered: [33.833333333333336, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 33.8 times with a 9.4 weekly interval (319.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2011.4
first_seen: 2019-08-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-08-29
last_seen_parent: 2025-12-31
average_administered: [12.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.8 times with a 14.4 weekly interval (185.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 3193.63
first_seen: 2019-08-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-08-23
last_seen_parent: 2025-12-31
average_administered: [2.870967741935484, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.9 times with a 18.1 weekly interval (53.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 20622.66
first_seen: 2022-12-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2022-12-06
last_seen_parent: 2025-12-30
average_administered: [10.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma - ATEZOLIZUMAB

average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 10.9 times with a 3.3 weekly interval (36.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 21586.91
first_seen: 2024-08-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-08-16
last_seen_parent: 2025-12-30
average_administered: [7.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: lung cancer
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 7.6 times with a 3.4 weekly interval (26.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3135.45
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [23.36196319018405, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23.4 times with a 11.4 weekly interval (267.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4327.91
first_seen: 2023-03-14T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2023-03-14
last_seen_parent: 2025-12-30
average_administered: [7.535714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 7.5 times with a 7.3 weekly interval (55.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3287.24
first_seen: 2023-03-10T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2023-01-24
last_seen_parent: 2025-09-26
average_administered: [4.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.8 times with a 17.1 weekly interval (82.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - migraine - GALCANEZUMAB
labels: GALCANEZUMAB
cost_pp_pa: 1852.58
first_seen: 2022-01-11T00:00:00
last_seen: 2025-09-26T00:00:00
first_seen_parent: 2022-01-11
last_seen_parent: 2025-09-26
average_administered: [9.777777777777779, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: migraine
drug_sequence: GALCANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>GALCANEZUMAB</b><br>On average given 9.8 times with a 19.0 weekly interval (186.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3627.62
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [20.044117647058822, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.0 times with a 11.7 weekly interval (234.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 7932.45
first_seen: 2023-05-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-31
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.0 times with a 21.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 3046.18
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [9.548913043478262, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9.5 times with a 11.9 weekly interval (113.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2858.31
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-19
average_administered: [12.666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.7 times with a 1.9 weekly interval (24.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 326.73
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-30
average_administered: [18.11111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: colorectal cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18.1 times with a 9.4 weekly interval (171.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3504.7
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-31
average_administered: [16.62264150943396, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16.6 times with a 6.3 weekly interval (104.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 11241.08
first_seen: 2019-06-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-21
last_seen_parent: 2025-12-31
average_administered: [32.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 32.2 times with a 7.0 weekly interval (225.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: RITUXIMAB
cost_pp_pa: 3836.23
first_seen: 2019-07-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-07-04
last_seen_parent: 2025-12-31
average_administered: [11.615384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.6 times with a 2.9 weekly interval (33.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 1565.41
first_seen: 2021-03-29T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2021-03-29
last_seen_parent: 2025-12-30
average_administered: [12.470588235294118, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 12.5 times with a 8.0 weekly interval (100.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 2827.42
first_seen: 2024-04-09T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-09
last_seen_parent: 2025-12-24
average_administered: [7.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.9 times with a 1.3 weekly interval (10.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: TOCILIZUMAB
cost_pp_pa: 104992.98
first_seen: 2025-02-12T00:00:00
last_seen: 2025-09-18T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-09-18
average_administered: [3.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 3.1 times with a 0.1 weekly interval (0.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2165.52
first_seen: 2019-06-27T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-27
last_seen_parent: 2025-12-24
average_administered: [19.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19.8 times with a 9.4 weekly interval (187.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: APREMILAST
cost_pp_pa: 3770.38
first_seen: 2020-07-05T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2019-10-04
last_seen_parent: 2025-12-19
average_administered: [23.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - APREMILAST

average_spacing:
<br><b>APREMILAST</b><br>On average given 23.0 times with a 12.4 weekly interval (286.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 6281.99
first_seen: 2022-09-08T00:00:00
last_seen: 2025-11-13T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-11-13
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 5.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 3951.48
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-30
average_administered: [25.72, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25.7 times with a 8.6 weekly interval (220.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 7414.26
first_seen: 2019-07-12T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2019-07-05
last_seen_parent: 2025-12-19
average_administered: [27.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 27.5 times with a 17.4 weekly interval (479.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 3919.39
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-24
average_administered: [25.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25.5 times with a 8.1 weekly interval (208.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 4266.79
first_seen: 2019-06-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-28
last_seen_parent: 2025-12-31
average_administered: [21.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21.0 times with a 5.7 weekly interval (120.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 1926.58
first_seen: 2019-09-28T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-09-28
last_seen_parent: 2025-12-30
average_administered: [12.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12.1 times with a 11.6 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx)
labels: FREMANEZUMAB
cost_pp_pa: 2833.53
first_seen: 2023-09-03T00:00:00
last_seen: 2025-09-16T00:00:00
first_seen_parent: 2023-09-03
last_seen_parent: 2025-09-16
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - NEUROLOGY (no GP dx) - FREMANEZUMAB

average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 4.0 times with a 14.1 weekly interval (57.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 5026.36
first_seen: 2019-06-05T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2019-06-05
last_seen_parent: 2025-12-31
average_administered: [20.272727272727273, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20.3 times with a 6.6 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: USTEKINUMAB
cost_pp_pa: 9417.08
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-19
average_administered: [33.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - USTEKINUMAB

average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 33.0 times with a 9.9 weekly interval (325.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY (no GP dx)
labels: OCTREOTIDE
cost_pp_pa: 1500.7
first_seen: 2021-04-06T00:00:00
last_seen: 2025-12-10T00:00:00
first_seen_parent: 2021-04-06
last_seen_parent: 2025-12-10
average_administered: [4.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: OCTREOTIDE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - MEDICAL ONCOLOGY (no GP dx) - OCTREOTIDE

average_spacing:
<br><b>OCTREOTIDE</b><br>On average given 4.8 times with a 16.1 weekly interval (77.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx)
labels: EVOLOCUMAB
cost_pp_pa: 1789.12
first_seen: 2019-08-26T00:00:00
last_seen: 2025-09-08T00:00:00
first_seen_parent: 2019-08-26
last_seen_parent: 2025-10-29
average_administered: [18.285714285714285, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ENDOCRINOLOGY (no GP dx)
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ENDOCRINOLOGY (no GP dx) - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 18.3 times with a 8.6 weekly interval (157.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: AFLIBERCEPT
cost_pp_pa: 3431.63
first_seen: 2019-06-03T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2019-06-03
last_seen_parent: 2025-12-27
average_administered: [20.066666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20.1 times with a 12.3 weekly interval (247.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 290.73
first_seen: 2019-06-04T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2019-06-04
last_seen_parent: 2025-12-26
average_administered: [13.155555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13.2 times with a 10.4 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 5106.89
first_seen: 2019-07-31T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-24
last_seen_parent: 2025-12-30
average_administered: [6.222222222222222, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6.2 times with a 7.6 weekly interval (47.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 7594.72
first_seen: 2019-09-18T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2019-09-18
last_seen_parent: 2025-12-24
average_administered: [10.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 10.1 times with a 9.0 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1617.5
first_seen: 2019-06-11T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2019-06-11
last_seen_parent: 2025-12-19
average_administered: [22.642857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22.6 times with a 10.1 weekly interval (229.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 295.77
first_seen: 2019-06-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-30
average_administered: [14.28, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 14.3 times with a 9.1 weekly interval (131.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7980.56
first_seen: 2019-04-08T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2019-04-08
last_seen_parent: 2025-12-29
average_administered: [24.242424242424242, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24.2 times with a 12.9 weekly interval (311.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - IMMUNOGLOBULIN
labels: IMMUNOGLOBULIN
cost_pp_pa: 33669.08
first_seen: 2024-04-19T00:00:00
last_seen: 2025-08-08T00:00:00
first_seen_parent: 2024-04-19
last_seen_parent: 2025-08-08
average_administered: [19.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 19.0 times with a 2.1 weekly interval (41.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3985.98
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-31
average_administered: [7.366666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.4 times with a 3.4 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2738.59
first_seen: 2020-10-14T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2019-04-28
last_seen_parent: 2025-12-31
average_administered: [11.10204081632653, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11.1 times with a 8.9 weekly interval (98.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - BREAST SURGERY (no GP dx) - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1259.41
first_seen: 2025-05-30T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-05-30
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: BREAST SURGERY (no GP dx)
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.5 times with a 2.7 weekly interval (10.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB
labels: ACALABRUTINIB
cost_pp_pa: 32546.8
first_seen: 2024-05-01T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-12-19
average_administered: [11.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 11.4 times with a 4.9 weekly interval (55.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 529.59
first_seen: 2025-03-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-11
last_seen_parent: 2025-12-31
average_administered: [1.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.8 times with a 6.7 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 1907.7
first_seen: 2025-05-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-05-12
last_seen_parent: 2025-12-30
average_administered: [3.5714285714285716, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.6 times with a 4.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 2949.89
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-30
average_administered: [3.0, 2.25, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.0 times with a 3.1 weekly interval (9.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 2.2 times with a 2.3 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2075.1
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-23
average_administered: [1.4, 3.2, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.4 times with a 4.0 weekly interval (6.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.2 times with a 0.7 weekly interval (2.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5991.73
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [3.8333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.8 times with a 5.7 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1258.21
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-29
average_administered: [3.2666666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.3 times with a 8.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2896.83
first_seen: 2025-05-02T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-05-02
last_seen_parent: 2025-12-19
average_administered: [11.736842105263158, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.7 times with a 1.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1451.15
first_seen: 2025-04-04T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2025-04-04
last_seen_parent: 2025-11-27
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.0 times with a 5.4 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 7477.11
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-30
average_administered: [3.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.2 times with a 3.9 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4869.32
first_seen: 2025-03-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-24
last_seen_parent: 2025-12-30
average_administered: [3.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.8 times with a 6.0 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1727.56
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [3.021978021978022, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.0 times with a 5.6 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3153.74
first_seen: 2025-06-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-06-16
last_seen_parent: 2025-12-30
average_administered: [5.444444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.4 times with a 2.0 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1155.68
first_seen: 2025-03-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-20
last_seen_parent: 2025-12-29
average_administered: [2.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.4 times with a 10.1 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2362.42
first_seen: 2025-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-12-30
average_administered: [4.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.1 times with a 6.1 weekly interval (25.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 20002.08
first_seen: 2025-03-03T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-09-25
average_administered: [5.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 5.8 times with a 2.0 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 6028.48
first_seen: 2025-03-12T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-12
last_seen_parent: 2025-12-31
average_administered: [7.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.9 times with a 1.0 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 22676.18
first_seen: 2025-10-17T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2025-10-17
last_seen_parent: 2025-12-02
average_administered: [1.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 1.1 times with a 0.7 weekly interval (1.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 7298.29
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-24
average_administered: [4.631578947368421, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.6 times with a 3.4 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: RISANKIZUMAB
cost_pp_pa: 23860.63
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-31
average_administered: [4.538461538461538, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB

average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 4.5 times with a 5.1 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 487.4
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [1.6428571428571428, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.6 times with a 7.7 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2806.53
first_seen: 2025-02-18T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-23
average_administered: [2.6486486486486487, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.6 times with a 4.4 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 1775.5
first_seen: 2025-02-27T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-27
last_seen_parent: 2025-12-30
average_administered: [5.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.7 times with a 7.1 weekly interval (41.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2974.74
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-24
average_administered: [3.466666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.5 times with a 3.9 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5406.6
first_seen: 2025-02-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-30
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5.0 times with a 3.4 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 12604.36
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-18
average_administered: [2.466666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 2.5 times with a 8.7 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1726.62
first_seen: 2025-02-25T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2025-02-25
last_seen_parent: 2025-12-08
average_administered: [5.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.8 times with a 7.0 weekly interval (41.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 40871.69
first_seen: 2025-03-13T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2025-03-13
last_seen_parent: 2025-12-15
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 6.0 times with a 4.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 5878.08
first_seen: 2025-03-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-11
last_seen_parent: 2025-12-31
average_administered: [7.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.4 times with a 1.4 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 5841.86
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-30
average_administered: [4.58252427184466, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.6 times with a 3.7 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: VEDOLIZUMAB
cost_pp_pa: 29600.61
first_seen: 2025-05-16T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-05-16
last_seen_parent: 2025-12-31
average_administered: [4.090909090909091, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4.1 times with a 3.9 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: DUPILUMAB
cost_pp_pa: 11498.44
first_seen: 2025-03-17T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2025-03-17
last_seen_parent: 2025-12-11
average_administered: [2.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - DUPILUMAB

average_spacing:
<br><b>DUPILUMAB</b><br>On average given 2.8 times with a 11.6 weekly interval (32.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 6407.2
first_seen: 2025-03-28T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2025-03-28
last_seen_parent: 2025-11-19
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx) - OMALIZUMAB

average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 5.0 times with a 3.4 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 7950.89
first_seen: 2025-02-17T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-02
average_administered: [3.276595744680851, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.3 times with a 4.4 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2655.52
first_seen: 2025-02-17T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-11
average_administered: [2.6041666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.6 times with a 3.4 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: RITUXIMAB
cost_pp_pa: 4783.32
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [10.387096774193548, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.4 times with a 1.6 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis
labels: TOCILIZUMAB
cost_pp_pa: 13054.82
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-29
average_administered: [6.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: giant cell arteritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis - TOCILIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 6.6 times with a 3.4 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: AFLIBERCEPT
cost_pp_pa: 5311.27
first_seen: 2025-04-29T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2025-04-29
last_seen_parent: 2025-11-14
average_administered: [3.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.4 times with a 6.4 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: RANIBIZUMAB
cost_pp_pa: 2598.92
first_seen: 2025-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-23
average_administered: [2.7260273972602738, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.7 times with a 4.1 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: INFLIXIMAB
cost_pp_pa: 4572.8
first_seen: 2025-02-26T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-26
last_seen_parent: 2025-12-30
average_administered: [4.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.8 times with a 4.4 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ADALIMUMAB
cost_pp_pa: 2847.21
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-30
average_administered: [3.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.9 times with a 5.1 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 2869.66
first_seen: 2025-02-25T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-25
last_seen_parent: 2025-12-18
average_administered: [2.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - RITUXIMAB

average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.2 times with a 6.6 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ADALIMUMAB
cost_pp_pa: 1962.23
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [5.678571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.7 times with a 6.6 weekly interval (37.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 3882.4
first_seen: 2025-03-07T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2025-03-07
last_seen_parent: 2025-12-22
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - FILGOTINIB

average_spacing:
<br><b>FILGOTINIB</b><br>On average given 5.0 times with a 2.7 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 8713.89
first_seen: 2025-07-21T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-07-21
last_seen_parent: 2025-12-24
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.0 times with a 2.0 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 11420.24
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-29
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.0 times with a 4.9 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 25856.43
first_seen: 2025-04-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-04-09
last_seen_parent: 2025-12-31
average_administered: [4.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4.8 times with a 4.4 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4430.12
first_seen: 2025-03-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-10
last_seen_parent: 2025-12-31
average_administered: [5.636363636363637, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.6 times with a 3.3 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1985.67
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-19
average_administered: [3.727272727272727, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.7 times with a 4.9 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: ADALIMUMAB
cost_pp_pa: 2086.67
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-29
average_administered: [5.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.2 times with a 6.0 weekly interval (31.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 6137.61
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-31
average_administered: [3.6363636363636362, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.6 times with a 3.6 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 10311.42
first_seen: 2025-04-25T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-23
average_administered: [4.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.3 times with a 4.0 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - RISANKIZUMAB
labels: RISANKIZUMAB
cost_pp_pa: 25205.91
first_seen: 2025-05-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-05-23
last_seen_parent: 2025-12-31
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 4.0 times with a 4.4 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 974.41
first_seen: 2025-03-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-07
last_seen_parent: 2025-12-29
average_administered: [2.6666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.7 times with a 12.1 weekly interval (33.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4904.97
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [3.740740740740741, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.7 times with a 6.1 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6316.24
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-23
average_administered: [4.352941176470588, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.4 times with a 4.6 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2965.27
first_seen: 2025-09-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-09-29
last_seen_parent: 2025-12-31
average_administered: [2.0526315789473686, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.1 times with a 2.3 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1797.22
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [2.864864864864865, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.9 times with a 7.9 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 6673.81
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-17
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 3.0 times with a 9.4 weekly interval (28.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1321.02
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-19
average_administered: [2.3333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.3 times with a 8.6 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4927.75
first_seen: 2025-02-18T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-31
average_administered: [4.35, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.3 times with a 5.9 weekly interval (25.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6330.71
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-31
average_administered: [4.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.1 times with a 4.4 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 4515.96
first_seen: 2025-04-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-04-10
last_seen_parent: 2025-12-31
average_administered: [4.153846153846154, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.2 times with a 3.1 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 8925.34
first_seen: 2025-04-30T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-13
last_seen_parent: 2025-12-30
average_administered: [3.9473684210526314, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.9 times with a 4.3 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 25649.5
first_seen: 2025-06-12T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-06-12
last_seen_parent: 2025-12-23
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4.2 times with a 4.7 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2551.16
first_seen: 2025-03-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-07
last_seen_parent: 2025-12-29
average_administered: [3.4583333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 7.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 7344.27
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-31
average_administered: [4.235294117647059, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.2 times with a 3.7 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3630.8
first_seen: 2025-04-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-04-10
last_seen_parent: 2025-12-31
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.0 times with a 3.7 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2514.0
first_seen: 2025-10-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-10-03
last_seen_parent: 2025-12-31
average_administered: [1.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 1.9 times with a 2.9 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 115974.78
first_seen: 2025-08-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-08-13
last_seen_parent: 2025-12-31
average_administered: [1.1666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.2 times with a 0.6 weekly interval (1.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1334.9
first_seen: 2025-04-02T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-04-02
last_seen_parent: 2025-12-29
average_administered: [4.083333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.1 times with a 2.7 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6574.02
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-21
average_administered: [3.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.8 times with a 5.0 weekly interval (19.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1674.25
first_seen: 2025-03-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-10
last_seen_parent: 2025-12-30
average_administered: [2.3461538461538463, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.3 times with a 6.9 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2530.64
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-01
average_administered: [2.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.8 times with a 6.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2212.09
first_seen: 2025-05-01T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-05-01
last_seen_parent: 2025-12-29
average_administered: [4.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.3 times with a 5.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 18718.57
first_seen: 2025-04-16T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2025-04-16
last_seen_parent: 2025-12-23
average_administered: [2.3333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 2.3 times with a 4.9 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1165.27
first_seen: 2025-03-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-11-26
average_administered: [2.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.2 times with a 12.3 weekly interval (27.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4615.49
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.2 times with a 6.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 9515.65
first_seen: 2025-05-01T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-05-01
last_seen_parent: 2025-12-17
average_administered: [2.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 2.9 times with a 3.3 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4009.18
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.5 times with a 9.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1289.18
first_seen: 2025-04-17T00:00:00
last_seen: 2025-10-31T00:00:00
first_seen_parent: 2025-04-17
last_seen_parent: 2025-10-31
average_administered: [2.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.8 times with a 7.3 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 1675.9
first_seen: 2025-05-19T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2025-05-19
last_seen_parent: 2025-12-21
average_administered: [3.4210526315789473, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.4 times with a 5.1 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2307.31
first_seen: 2025-08-16T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2025-08-16
last_seen_parent: 2025-12-16
average_administered: [1.6666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.7 times with a 1.0 weekly interval (2.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 15138.28
first_seen: 2025-08-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-08-11
last_seen_parent: 2025-12-30
average_administered: [1.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 1.4 times with a 2.9 weekly interval (4.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 603.85
first_seen: 2025-03-11T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-11
last_seen_parent: 2025-12-31
average_administered: [1.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.6 times with a 5.3 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3113.07
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-19
average_administered: [11.608695652173912, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11.6 times with a 1.4 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 23842.0
first_seen: 2025-02-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-30
average_administered: [5.641025641025641, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 5.6 times with a 3.1 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - lung cancer - ATEZOLIZUMAB
labels: ATEZOLIZUMAB
cost_pp_pa: 22137.61
first_seen: 2025-03-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-05
last_seen_parent: 2025-12-30
average_administered: [6.571428571428571, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: lung cancer
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 6.6 times with a 3.4 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: RITUXIMAB
cost_pp_pa: 4386.11
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [10.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.7 times with a 1.6 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1747.05
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [2.89, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.9 times with a 5.4 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 16820.31
first_seen: 2025-04-14T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-04-14
last_seen_parent: 2025-12-30
average_administered: [1.3333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 1.3 times with a 2.3 weekly interval (3.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 81655.71
first_seen: 2025-04-03T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-04-03
last_seen_parent: 2025-12-31
average_administered: [1.2857142857142858, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.3 times with a 0.9 weekly interval (1.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6606.09
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-21
average_administered: [3.7142857142857144, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 3.7 times with a 5.0 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 3252.05
first_seen: 2025-05-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-05-23
last_seen_parent: 2025-12-30
average_administered: [5.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.1 times with a 1.7 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 335.28
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-29
average_administered: [6.571428571428571, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 6.6 times with a 1.9 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: IMMUNOGLOBULIN
cost_pp_pa: 39394.0
first_seen: 2025-02-21T00:00:00
last_seen: 2025-09-25T00:00:00
first_seen_parent: 2025-02-21
last_seen_parent: 2025-09-25
average_administered: [5.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 5.2 times with a 1.3 weekly interval (7.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2693.81
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-30
average_administered: [4.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.3 times with a 5.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 6665.82
first_seen: 2025-03-28T00:00:00
last_seen: 2025-11-19T00:00:00
first_seen_parent: 2025-03-28
last_seen_parent: 2025-11-19
average_administered: [4.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 4.3 times with a 2.9 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1271.21
first_seen: 2025-03-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-11-26
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.0 times with a 10.1 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 7731.17
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-31
average_administered: [8.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8.0 times with a 0.9 weekly interval (7.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 24190.45
first_seen: 2025-06-14T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2025-06-14
last_seen_parent: 2025-12-02
average_administered: [1.0909090909090908, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 1.1 times with a 0.6 weekly interval (1.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1920.36
first_seen: 2025-02-16T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-16
last_seen_parent: 2025-12-30
average_administered: [2.9855072463768115, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.0 times with a 5.3 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: RISANKIZUMAB
cost_pp_pa: 24362.88
first_seen: 2025-02-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-21
last_seen_parent: 2025-12-31
average_administered: [4.428571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: RISANKIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RISANKIZUMAB</b><br>On average given 4.4 times with a 5.1 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 3386.72
first_seen: 2025-02-25T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-25
last_seen_parent: 2025-12-18
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.0 times with a 5.0 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 611.91
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [1.45, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.4 times with a 5.4 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2898.13
first_seen: 2025-02-17T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-23
average_administered: [2.5245901639344264, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.5 times with a 3.7 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 31137.2
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-08
average_administered: [1.1764705882352942, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.2 times with a 2.1 weekly interval (3.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 6875.93
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-29
average_administered: [4.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4.2 times with a 4.1 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: IMMUNOGLOBULIN
cost_pp_pa: 91880.71
first_seen: 2025-03-26T00:00:00
last_seen: 2025-09-03T00:00:00
first_seen_parent: 2025-03-26
last_seen_parent: 2025-09-03
average_administered: [5.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: IMMUNOGLOBULIN
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - IMMUNOGLOBULIN

average_spacing:
<br><b>IMMUNOGLOBULIN</b><br>On average given 5.1 times with a 1.4 weekly interval (7.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 3197.56
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-24
average_administered: [3.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.2 times with a 3.6 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 5390.86
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-30
average_administered: [4.944444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4.9 times with a 3.6 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: ACALABRUTINIB
cost_pp_pa: 41902.0
first_seen: 2025-02-13T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-12-15
average_administered: [5.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 5.5 times with a 3.9 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 5609.19
first_seen: 2025-02-19T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-19
last_seen_parent: 2025-12-31
average_administered: [7.5813953488372094, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.6 times with a 1.4 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 5960.68
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-30
average_administered: [4.37719298245614, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.4 times with a 3.6 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 8168.68
first_seen: 2025-02-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-02
average_administered: [3.2222222222222223, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.2 times with a 4.1 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2722.76
first_seen: 2025-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-11
average_administered: [2.6375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.6 times with a 3.7 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: OBINUTUZUMAB
cost_pp_pa: 41146.25
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-31
average_administered: [7.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: OBINUTUZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OBINUTUZUMAB</b><br>On average given 7.8 times with a 1.9 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - follicular lymphoma
labels: RITUXIMAB
cost_pp_pa: 4919.95
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-31
average_administered: [9.987804878048781, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.0 times with a 1.4 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 7609.71
first_seen: 2025-02-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-12
last_seen_parent: 2025-12-24
average_administered: [4.173913043478261, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.2 times with a 3.0 weekly interval (13.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: RANIBIZUMAB
cost_pp_pa: 2608.54
first_seen: 2025-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-23
average_administered: [2.76, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.8 times with a 4.1 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: ADALIMUMAB
cost_pp_pa: 2586.77
first_seen: 2025-06-07T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2025-06-07
last_seen_parent: 2025-12-11
average_administered: [2.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.0 times with a 4.3 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ADALIMUMAB
cost_pp_pa: 1975.79
first_seen: 2025-02-07T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-07
last_seen_parent: 2025-12-30
average_administered: [5.2727272727272725, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.3 times with a 6.7 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 9530.07
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-24
average_administered: [2.8823529411764706, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.9 times with a 2.3 weekly interval (7.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
labels: BEVACIZUMAB
cost_pp_pa: 730.4
first_seen: 2025-03-02T00:00:00
last_seen: 2025-12-04T00:00:00
first_seen_parent: 2025-03-02
last_seen_parent: 2025-12-04
average_administered: [2.1666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.2 times with a 5.1 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: UPADACITINIB
cost_pp_pa: 16281.88
first_seen: 2025-02-11T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2025-02-11
last_seen_parent: 2025-11-25
average_administered: [2.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - UPADACITINIB

average_spacing:
<br><b>UPADACITINIB</b><br>On average given 2.5 times with a 4.0 weekly interval (10.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5256.62
first_seen: 2025-02-13T00:00:00
last_seen: 2025-11-14T00:00:00
first_seen_parent: 2025-02-13
last_seen_parent: 2025-11-14
average_administered: [4.333333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.3 times with a 5.4 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 6202.28
first_seen: 2025-02-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-28
last_seen_parent: 2025-12-31
average_administered: [3.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.5 times with a 3.4 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - CLINICAL HAEMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5047.91
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-31
average_administered: [5.2631578947368425, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.3 times with a 2.3 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - MEDICAL ONCOLOGY (no GP dx) - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1398.35
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-18
average_administered: [4.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: MEDICAL ONCOLOGY (no GP dx)
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.8 times with a 2.6 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 3656.64
first_seen: 2025-03-07T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2025-03-07
last_seen_parent: 2025-12-22
average_administered: [4.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 4.7 times with a 3.6 weekly interval (17.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1812.26
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [2.8157894736842106, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.8 times with a 7.6 weekly interval (21.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - chronic lymphocytic leukaemia - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 5017.65
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-31
average_administered: [4.157894736842105, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.2 times with a 2.6 weekly interval (11.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 7538.94
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-17
average_administered: [2.3333333333333335, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 2.3 times with a 6.3 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1416.04
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-19
average_administered: [2.142857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.1 times with a 7.3 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - breast cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1660.11
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-19
average_administered: [3.8666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: breast cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 3.9 times with a 2.3 weekly interval (9.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 8866.74
first_seen: 2025-02-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-24
last_seen_parent: 2025-12-30
average_administered: [3.52, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 3.5 times with a 4.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4779.29
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.117647058823529, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.1 times with a 6.0 weekly interval (25.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - follicular lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3845.88
first_seen: 2025-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-26
last_seen_parent: 2025-12-31
average_administered: [5.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: follicular lymphoma
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5.8 times with a 3.4 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 5044.71
first_seen: 2025-02-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-06
last_seen_parent: 2025-12-31
average_administered: [4.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.0 times with a 6.1 weekly interval (25.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 6413.19
first_seen: 2025-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-06
last_seen_parent: 2025-12-31
average_administered: [4.0588235294117645, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.1 times with a 4.3 weekly interval (18.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1700.76
first_seen: 2025-03-17T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-03-10
last_seen_parent: 2025-12-30
average_administered: [2.2962962962962963, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 2.3 times with a 6.6 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 3168.92
first_seen: 2025-03-03T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2025-03-03
last_seen_parent: 2025-12-01
average_administered: [2.5714285714285716, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.6 times with a 5.3 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 7856.31
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-30
average_administered: [3.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.0 times with a 4.7 weekly interval (14.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4994.53
first_seen: 2025-02-20T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-20
last_seen_parent: 2025-12-29
average_administered: [3.6129032258064515, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.6 times with a 6.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - prostate cancer - DOCETAXEL
labels: DOCETAXEL
cost_pp_pa: 1480.76
first_seen: 2025-02-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2025-02-18
last_seen_parent: 2025-12-29
average_administered: [4.647058823529412, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: prostate cancer
drug_sequence: DOCETAXEL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DOCETAXEL</b><br>On average given 4.6 times with a 2.7 weekly interval (12.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 7596.54
first_seen: 2025-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-14
last_seen_parent: 2025-12-31
average_administered: [4.140350877192983, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 4.1 times with a 3.6 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4248.76
first_seen: 2025-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-03-04
last_seen_parent: 2025-12-31
average_administered: [3.1, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 3.1 times with a 8.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 4828.43
first_seen: 2025-02-26T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2025-02-26
last_seen_parent: 2025-12-24
average_administered: [7.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7.3 times with a 0.7 weekly interval (5.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 5262.5
first_seen: 2025-02-10T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2025-02-10
last_seen_parent: 2025-12-31
average_administered: [4.396825396825397, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4.4 times with a 4.6 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 1013.46
first_seen: 2025-02-17T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2025-02-17
last_seen_parent: 2025-12-26
average_administered: [2.103448275862069, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.1 times with a 3.7 weekly interval (8.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 1772.24
first_seen: 2025-02-22T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2025-02-22
last_seen_parent: 2025-12-21
average_administered: [3.1904761904761907, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.2 times with a 4.6 weekly interval (15.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 546.87
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-30
average_administered: [5.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.8 times with a 10.4 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4689.53
first_seen: 2024-12-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-12-05
last_seen_parent: 2025-12-30
average_administered: [4.8, 2.2, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.8 times with a 5.6 weekly interval (27.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 2.2 times with a 5.7 weekly interval (13.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2913.53
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-21
average_administered: [4.75, 5.0, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.8 times with a 13.0 weekly interval (62.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.0 times with a 10.4 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: 2689.57
first_seen: 2024-06-12T00:00:00
last_seen: 2025-11-30T00:00:00
first_seen_parent: 2024-04-08
last_seen_parent: 2025-11-30
average_administered: [3.75, 2.75, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.8 times with a 1.0 weekly interval (4.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 2.8 times with a 10.0 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 2517.11
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.0, 4.125, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.0 times with a 11.4 weekly interval (46.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.1 times with a 7.4 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3151.45
first_seen: 2024-03-26T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-03-26
last_seen_parent: 2025-12-08
average_administered: [6.4, 3.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.4 times with a 7.1 weekly interval (46.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.0 times with a 3.1 weekly interval (9.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2479.69
first_seen: 2024-03-18T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-03-18
last_seen_parent: 2025-12-23
average_administered: [3.0, 6.125, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.0 times with a 18.9 weekly interval (57.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.1 times with a 5.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4454.24
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [5.0, 3.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT - FARICIMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.0 times with a 6.3 weekly interval (31.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 3.0 times with a 5.6 weekly interval (17.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3070.79
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.909090909090909, 5.181818181818182, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB

average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.9 times with a 9.3 weekly interval (46.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.2 times with a 9.4 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2553.86
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-31
average_administered: [4.295454545454546, 5.386363636363637, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.3 times with a 10.7 weekly interval (46.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.4 times with a 5.7 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1455.56
first_seen: 2024-03-15T00:00:00
last_seen: 2025-11-10T00:00:00
first_seen_parent: 2024-03-15
last_seen_parent: 2025-11-10
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 9.9 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4746.13
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-03T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-03
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.0 times with a 6.4 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8408.54
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-29
average_administered: [5.733333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 5.7 times with a 8.3 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 8175.09
first_seen: 2024-04-05T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-05
last_seen_parent: 2025-12-24
average_administered: [6.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 6.4 times with a 8.4 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1037.81
first_seen: 2024-06-06T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-06-06
last_seen_parent: 2025-11-26
average_administered: [3.375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.4 times with a 14.9 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 363.02
first_seen: 2024-04-30T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-30
last_seen_parent: 2025-12-30
average_administered: [3.4444444444444446, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 3.4 times with a 5.0 weekly interval (17.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 1140.08
first_seen: 2024-05-03T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-05-03
last_seen_parent: 2025-12-19
average_administered: [5.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ADALIMUMAB

average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.9 times with a 10.4 weekly interval (62.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2323.46
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-29
average_administered: [5.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.8 times with a 9.1 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 3826.39
first_seen: 2024-05-15T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-05-15
last_seen_parent: 2025-12-30
average_administered: [6.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 6.0 times with a 6.9 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1333.13
first_seen: 2024-02-09T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.97093023255814, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5.0 times with a 8.9 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ovarian cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 2533.46
first_seen: 2024-09-24T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-09-24
last_seen_parent: 2025-12-30
average_administered: [8.454545454545455, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ovarian cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 8.5 times with a 2.6 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 469.49
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-26
average_administered: [5.0625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.1 times with a 6.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 1769.49
first_seen: 2024-08-27T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-06-24
last_seen_parent: 2025-12-30
average_administered: [4.041666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.0 times with a 6.3 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2587.36
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-02
average_administered: [4.592592592592593, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.6 times with a 10.0 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1860.57
first_seen: 2024-07-03T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-07-03
last_seen_parent: 2025-12-30
average_administered: [7.066666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.1 times with a 7.3 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 4663.55
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-16
average_administered: [10.615384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 10.6 times with a 4.4 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: ADALIMUMAB
cost_pp_pa: 1856.4
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-29
average_administered: [8.755102040816327, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.8 times with a 7.7 weekly interval (68.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: AFLIBERCEPT
cost_pp_pa: 4484.22
first_seen: 2024-02-29T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-23
average_administered: [4.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.8 times with a 10.3 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: RANIBIZUMAB
cost_pp_pa: 2027.87
first_seen: 2024-02-29T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-31
average_administered: [4.602409638554217, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.6 times with a 6.4 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2687.37
first_seen: 2024-04-30T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-30
last_seen_parent: 2025-12-24
average_administered: [5.55, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.5 times with a 4.6 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 1044.7
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-18
average_administered: [2.769230769230769, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.8 times with a 13.9 weekly interval (39.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: SECUKINUMAB
cost_pp_pa: 7703.75
first_seen: 2024-05-10T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-05-10
last_seen_parent: 2025-12-29
average_administered: [6.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6.6 times with a 9.3 weekly interval (61.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 320.39
first_seen: 2024-08-07T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-07
last_seen_parent: 2025-12-31
average_administered: [2.0555555555555554, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.1 times with a 12.4 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2051.32
first_seen: 2024-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-23
average_administered: [4.074074074074074, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.1 times with a 6.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: CERTOLIZUMAB PEGOL
cost_pp_pa: 11713.42
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-18
average_administered: [4.166666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: CERTOLIZUMAB PEGOL
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - CERTOLIZUMAB PEGOL

average_spacing:
<br><b>CERTOLIZUMAB PEGOL</b><br>On average given 4.2 times with a 11.0 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: FILGOTINIB
cost_pp_pa: 2260.39
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-22
average_administered: [4.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: FILGOTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FILGOTINIB</b><br>On average given 4.9 times with a 6.9 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: RITUXIMAB
cost_pp_pa: 5522.08
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [4.111111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.1 times with a 6.3 weekly interval (26.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - giant cell arteritis
labels: TOCILIZUMAB
cost_pp_pa: 12368.91
first_seen: 2024-10-28T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-10-28
last_seen_parent: 2025-12-29
average_administered: [7.416666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: giant cell arteritis
drug_sequence: TOCILIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 7.4 times with a 3.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: INFLIXIMAB
cost_pp_pa: 3869.98
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-30
average_administered: [7.136363636363637, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.1 times with a 5.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
labels: VEDOLIZUMAB
cost_pp_pa: 17009.94
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.777777777777778, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6.8 times with a 5.3 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4739.72
first_seen: 2024-02-26T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [4.891891891891892, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.9 times with a 6.6 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4671.07
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [7.68, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.7 times with a 4.4 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 9409.29
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [3.9615384615384617, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.0 times with a 10.7 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4850.82
first_seen: 2024-05-22T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-05-22
last_seen_parent: 2025-12-11
average_administered: [9.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 9.8 times with a 4.1 weekly interval (41.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
labels: DUPILUMAB
cost_pp_pa: 9793.1
first_seen: 2024-05-10T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2024-05-10
last_seen_parent: 2025-11-25
average_administered: [4.714285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis - DUPILUMAB

average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.7 times with a 7.7 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 2055.63
first_seen: 2024-02-29T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.261904761904762, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.3 times with a 6.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 4346.69
first_seen: 2024-04-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-13
last_seen_parent: 2025-12-31
average_administered: [1.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.6 times with a 17.0 weekly interval (27.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1480.01
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-07
last_seen_parent: 2025-12-29
average_administered: [4.930232558139535, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.9 times with a 10.0 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: APREMILAST
cost_pp_pa: 6058.66
first_seen: 2024-09-02T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-09-02
last_seen_parent: 2025-12-15
average_administered: [5.2, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: APREMILAST
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>APREMILAST</b><br>On average given 5.2 times with a 7.7 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: INFLIXIMAB
cost_pp_pa: 5163.35
first_seen: 2024-07-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-10
last_seen_parent: 2025-12-30
average_administered: [6.285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.3 times with a 5.0 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
labels: SECUKINUMAB
cost_pp_pa: 15354.78
first_seen: 2024-11-29T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2024-04-22
last_seen_parent: 2025-12-02
average_administered: [3.5714285714285716, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: SECUKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - SECUKINUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 3.6 times with a 7.0 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: EVOLOCUMAB
cost_pp_pa: 2072.51
first_seen: 2024-03-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-18
last_seen_parent: 2025-12-30
average_administered: [11.333333333333334, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: primary hypercholesterolaemia
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - primary hypercholesterolaemia - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 11.3 times with a 5.6 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
labels: ADALIMUMAB
cost_pp_pa: 1539.59
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [9.090909090909092, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.1 times with a 7.9 weekly interval (72.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
labels: ADALIMUMAB
cost_pp_pa: 2342.84
first_seen: 2024-03-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-22
last_seen_parent: 2025-12-30
average_administered: [7.705882352941177, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.7 times with a 7.6 weekly interval (58.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 3092.25
first_seen: 2024-07-18T00:00:00
last_seen: 2025-12-15T00:00:00
first_seen_parent: 2024-07-18
last_seen_parent: 2025-12-15
average_administered: [2.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion - DEXAMETHASONE

average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 2.6 times with a 35.9 weekly interval (93.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: ADALIMUMAB
cost_pp_pa: 1735.34
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-30
average_administered: [8.76923076923077, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8.8 times with a 7.9 weekly interval (69.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
labels: UPADACITINIB
cost_pp_pa: 8928.68
first_seen: 2024-03-05T00:00:00
last_seen: 2025-12-12T00:00:00
first_seen_parent: 2024-03-05
last_seen_parent: 2025-12-12
average_administered: [7.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 7.5 times with a 6.4 weekly interval (48.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: DUPILUMAB
cost_pp_pa: 8820.47
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-06-06
last_seen_parent: 2025-12-11
average_administered: [3.1666666666666665, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 3.2 times with a 12.6 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2308.43
first_seen: 2024-04-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-04-15
last_seen_parent: 2025-12-16
average_administered: [10.25, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10.2 times with a 7.3 weekly interval (74.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 4693.44
first_seen: 2024-04-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-18
last_seen_parent: 2025-12-29
average_administered: [6.448275862068965, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.4 times with a 4.7 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - plaque psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1707.88
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [6.409090909090909, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: plaque psoriasis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.4 times with a 9.6 weekly interval (61.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 14547.48
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-31
average_administered: [7.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB

average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7.0 times with a 6.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3825.55
first_seen: 2024-05-05T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-05-05
last_seen_parent: 2025-12-30
average_administered: [6.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.4 times with a 5.1 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1417.67
first_seen: 2024-06-10T00:00:00
last_seen: 2025-12-22T00:00:00
first_seen_parent: 2024-06-10
last_seen_parent: 2025-12-22
average_administered: [6.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6.6 times with a 9.4 weekly interval (62.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - DERMATOLOGY (no GP dx) - UPADACITINIB
labels: UPADACITINIB
cost_pp_pa: 8327.93
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-31
average_administered: [4.2727272727272725, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: DERMATOLOGY (no GP dx)
drug_sequence: UPADACITINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>UPADACITINIB</b><br>On average given 4.3 times with a 7.6 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4507.86
first_seen: 2024-06-04T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-06-04
last_seen_parent: 2025-12-30
average_administered: [6.135135135135135, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.1 times with a 11.4 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1488.61
first_seen: 2024-02-08T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-02-08
last_seen_parent: 2025-12-19
average_administered: [4.615384615384615, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.6 times with a 10.1 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 8449.56
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [7.214285714285714, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.2 times with a 4.4 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 5071.52
first_seen: 2024-02-22T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-22
last_seen_parent: 2025-12-30
average_administered: [9.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9.0 times with a 8.3 weekly interval (75.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - GASTROENTEROLOGY (no GP dx) - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 19942.23
first_seen: 2024-05-16T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-16
last_seen_parent: 2025-12-31
average_administered: [6.625, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6.6 times with a 4.9 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1183.11
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-29
average_administered: [4.555555555555555, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.6 times with a 11.6 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3201.91
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-29
average_administered: [5.923076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.9 times with a 9.1 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - OPHTHALMOLOGY (no GP dx) - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 376.69
first_seen: 2024-04-19T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-04-19
last_seen_parent: 2025-12-08
average_administered: [2.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.4 times with a 8.9 weekly interval (21.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - NEUROLOGY (no GP dx) - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3130.33
first_seen: 2024-07-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-07-03
last_seen_parent: 2025-12-30
average_administered: [5.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: NEUROLOGY (no GP dx)
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 5.4 times with a 8.7 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4341.15
first_seen: 2024-06-25T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-06-25
last_seen_parent: 2025-12-24
average_administered: [3.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 3.4 times with a 4.1 weekly interval (14.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1701.35
first_seen: 2024-02-21T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-12-31
average_administered: [5.3936170212765955, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.4 times with a 10.1 weekly interval (55.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx)
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - RHEUMATOLOGY (no GP dx) - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4476.17
first_seen: 2024-06-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-06-06
last_seen_parent: 2025-12-31
average_administered: [6.7317073170731705, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6.7 times with a 11.9 weekly interval (79.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: ALIROCUMAB
cost_pp_pa: 2364.12
first_seen: 2024-02-13T00:00:00
last_seen: 2025-12-09T00:00:00
first_seen_parent: 2024-02-13
last_seen_parent: 2025-12-09
average_administered: [9.88888888888889, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: ALIROCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - ALIROCUMAB

average_spacing:
<br><b>ALIROCUMAB</b><br>On average given 9.9 times with a 7.3 weekly interval (72.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
labels: EVOLOCUMAB
cost_pp_pa: 2149.17
first_seen: 2024-03-18T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-18
last_seen_parent: 2025-12-30
average_administered: [9.142857142857142, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CHEMICAL PATHOLOGY (no GP dx)
drug_sequence: EVOLOCUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CHEMICAL PATHOLOGY (no GP dx) - EVOLOCUMAB

average_spacing:
<br><b>EVOLOCUMAB</b><br>On average given 9.1 times with a 7.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1609.9
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-31
average_administered: [4.916666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.9 times with a 10.7 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1942.61
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-19T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-19
average_administered: [7.2727272727272725, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.3 times with a 6.4 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: ACALABRUTINIB
cost_pp_pa: 36073.59
first_seen: 2024-05-08T00:00:00
last_seen: 2025-12-01T00:00:00
first_seen_parent: 2024-05-08
last_seen_parent: 2025-12-01
average_administered: [6.875, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 6.9 times with a 8.0 weekly interval (55.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - chronic lymphocytic leukaemia
labels: RITUXIMAB
cost_pp_pa: 4051.76
first_seen: 2024-04-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-04
last_seen_parent: 2025-12-31
average_administered: [10.947368421052632, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: chronic lymphocytic leukaemia
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10.9 times with a 2.9 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: 855.19
first_seen: 2024-02-28T00:00:00
last_seen: 2025-12-27T00:00:00
first_seen_parent: 2024-02-28
last_seen_parent: 2025-12-27
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: colorectal cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6.8 times with a 6.6 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 3939.27
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-14
last_seen_parent: 2025-12-31
average_administered: [6.434782608695652, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.4 times with a 5.3 weekly interval (34.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 4832.15
first_seen: 2024-07-12T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-07-12
last_seen_parent: 2025-12-16
average_administered: [4.125, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4.1 times with a 7.7 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1287.1
first_seen: 2024-02-12T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-11-20
average_administered: [5.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.6 times with a 9.7 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 4974.3
first_seen: 2025-01-25T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2025-01-25
last_seen_parent: 2025-12-30
average_administered: [2.7142857142857144, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 2.7 times with a 4.6 weekly interval (12.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - DEXAMETHASONE
labels: DEXAMETHASONE
cost_pp_pa: 4142.65
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-31
average_administered: [1.7777777777777777, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 12.7 weekly interval (23.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5581.31
first_seen: 2024-04-21T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2024-04-21
last_seen_parent: 2025-12-26
average_administered: [5.12, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.1 times with a 5.4 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: 1752.14
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [4.642857142857143, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.6 times with a 9.3 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - hepatocellular carcinoma
labels: ATEZOLIZUMAB
cost_pp_pa: 21355.5
first_seen: 2024-04-02T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-02
last_seen_parent: 2025-12-30
average_administered: [11.422222222222222, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: hepatocellular carcinoma
drug_sequence: ATEZOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ATEZOLIZUMAB</b><br>On average given 11.4 times with a 3.4 weekly interval (39.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1947.55
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-31
average_administered: [4.893939393939394, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.9 times with a 10.3 weekly interval (50.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 2553.25
first_seen: 2024-04-16T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-16
last_seen_parent: 2025-12-29
average_administered: [4.777777777777778, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.8 times with a 9.0 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1167.25
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-11
average_administered: [7.5, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7.5 times with a 12.9 weekly interval (96.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 6004.27
first_seen: 2024-03-20T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-20
last_seen_parent: 2025-12-30
average_administered: [6.62962962962963, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.6 times with a 4.7 weekly interval (31.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: 17126.37
first_seen: 2024-03-01T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-01
last_seen_parent: 2025-12-31
average_administered: [8.3, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: crohn's disease
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8.3 times with a 5.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 2801.51
first_seen: 2024-04-11T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-11
last_seen_parent: 2025-12-29
average_administered: [6.166666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.2 times with a 8.6 weekly interval (53.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - ulcerative colitis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: 7384.93
first_seen: 2024-03-15T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-03-15
last_seen_parent: 2025-12-30
average_administered: [4.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: ulcerative colitis
drug_sequence: USTEKINUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4.7 times with a 6.3 weekly interval (30.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 4597.55
first_seen: 2024-02-16T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-16
last_seen_parent: 2025-12-31
average_administered: [5.465753424657534, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.5 times with a 5.3 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3384.9
first_seen: 2024-02-14T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-09
last_seen_parent: 2025-12-31
average_administered: [7.016393442622951, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7.0 times with a 9.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - migraine - FREMANEZUMAB
labels: FREMANEZUMAB
cost_pp_pa: 3296.81
first_seen: 2024-04-03T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-04-03
last_seen_parent: 2025-12-30
average_administered: [6.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: migraine
drug_sequence: FREMANEZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FREMANEZUMAB</b><br>On average given 6.8 times with a 10.1 weekly interval (69.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 3871.72
first_seen: 2024-03-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-06
last_seen_parent: 2025-12-31
average_administered: [5.827586206896552, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.8 times with a 8.1 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1465.19
first_seen: 2024-03-15T00:00:00
last_seen: 2025-10-22T00:00:00
first_seen_parent: 2024-03-15
last_seen_parent: 2025-10-22
average_administered: [4.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4.9 times with a 8.1 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4873.98
first_seen: 2024-02-21T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-11-26
average_administered: [8.222222222222221, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.2 times with a 6.6 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 5441.44
first_seen: 2024-09-25T00:00:00
last_seen: 2025-12-17T00:00:00
first_seen_parent: 2024-09-25
last_seen_parent: 2025-12-17
average_administered: [4.818181818181818, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.8 times with a 5.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: 2977.11
first_seen: 2024-03-04T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-03-04
last_seen_parent: 2025-12-31
average_administered: [4.181818181818182, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4.2 times with a 10.6 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration
ids: N&WICS - WEST SUFFOLK NHS FOUNDATION TRUST - macular degeneration - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 5589.06
first_seen: 2024-04-12T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-12
last_seen_parent: 2025-12-29
average_administered: [5.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: WEST SUFFOLK NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>FARICIMAB</b><br>On average given 5.8 times with a 6.9 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - ulcerative colitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1491.69
first_seen: 2024-02-22T00:00:00
last_seen: 2025-11-13T00:00:00
first_seen_parent: 2024-02-22
last_seen_parent: 2025-11-13
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: ulcerative colitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 5.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx)
labels: ACALABRUTINIB
cost_pp_pa: 34770.19
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-08
average_administered: [7.75, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL HAEMATOLOGY (no GP dx)
drug_sequence: ACALABRUTINIB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL HAEMATOLOGY (no GP dx) - ACALABRUTINIB

average_spacing:
<br><b>ACALABRUTINIB</b><br>On average given 7.8 times with a 11.6 weekly interval (90.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 4636.01
first_seen: 2024-07-04T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-07-04
last_seen_parent: 2025-12-29
average_administered: [9.11111111111111, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9.1 times with a 5.0 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2660.15
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-31
average_administered: [8.23076923076923, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.2 times with a 6.3 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 4319.41
first_seen: 2024-07-12T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-07-12
last_seen_parent: 2025-12-24
average_administered: [5.4, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - ETANERCEPT

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5.4 times with a 6.7 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 1853.54
first_seen: 2024-08-06T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-06
last_seen_parent: 2025-12-31
average_administered: [6.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx) - INFLIXIMAB

average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6.6 times with a 5.0 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 490.7
first_seen: 2024-07-24T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-07-24
last_seen_parent: 2025-12-31
average_administered: [1.6470588235294117, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.6 times with a 7.4 weekly interval (12.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - non-small-cell lung cancer
labels: BEVACIZUMAB
cost_pp_pa: 516.56
first_seen: 2024-02-20T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-20
last_seen_parent: 2025-12-30
average_administered: [5.705882352941177, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: non-small-cell lung cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5.7 times with a 11.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB
ids: N&WICS - THE QUEEN ELIZABETH HOSPITAL - rheumatoid arthritis - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1606.3
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-08
average_administered: [3.4, 3.0, NaN, NaN, NaN, NaN, NaN]
trust_name: THE QUEEN ELIZABETH HOSPITAL
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.4 times with a 9.1 weekly interval (31.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 3.0 times with a 5.9 weekly interval (18.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 2469.06
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [3.8461538461538463, 4.269230769230769, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.8 times with a 11.3 weekly interval (43.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.3 times with a 6.9 weekly interval (29.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: RITUXIMAB
cost_pp_pa: 1596.96
first_seen: 2024-02-19T00:00:00
last_seen: 2025-11-27T00:00:00
first_seen_parent: 2024-02-19
last_seen_parent: 2025-11-27
average_administered: [5.833333333333333, 2.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.8 times with a 7.0 weekly interval (41.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 2.0 times with a 2.0 weekly interval (4.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB - FARICIMAB
labels: FARICIMAB
cost_pp_pa: 2862.24
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-21T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-21
average_administered: [4.62962962962963, 4.814814814814815, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.6 times with a 12.4 weekly interval (57.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 4.8 times with a 10.1 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2566.37
first_seen: 2024-02-29T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-31
average_administered: [4.311111111111111, 5.355555555555555, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.3 times with a 10.6 weekly interval (45.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.4 times with a 5.9 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - AFLIBERCEPT
labels: FARICIMAB
cost_pp_pa: 4761.46
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-23
average_administered: [5.25, 2.75, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: AFLIBERCEPT|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.2 times with a 6.3 weekly interval (33.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 2.8 times with a 4.9 weekly interval (14.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - diabetes - RANIBIZUMAB
labels: FARICIMAB
cost_pp_pa: 3050.73
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-31
average_administered: [4.75, 5.0, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: diabetes
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.8 times with a 8.9 weekly interval (43.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 5.0 times with a 9.4 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: FARICIMAB
cost_pp_pa: 2458.29
first_seen: 2024-03-18T00:00:00
last_seen: 2025-12-23T00:00:00
first_seen_parent: 2024-03-18
last_seen_parent: 2025-12-23
average_administered: [2.888888888888889, 6.666666666666667, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB|FARICIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 2.9 times with a 23.1 weekly interval (67.0 weeks total treatment length)<br><b>FARICIMAB</b><br>On average given 6.7 times with a 4.9 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CLINICAL IMMUNOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 4529.09
first_seen: 2024-05-01T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-05-01
last_seen_parent: 2025-11-26
average_administered: [13.857142857142858, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: CLINICAL IMMUNOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 13.9 times with a 2.9 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease
ids: N&WICS - CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: 4992.64
first_seen: 2024-02-21T00:00:00
last_seen: 2025-11-26T00:00:00
first_seen_parent: 2024-02-21
last_seen_parent: 2025-11-26
average_administered: [7.090909090909091, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: crohn's disease
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7.1 times with a 6.3 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 512.36
first_seen: 2024-02-23T00:00:00
last_seen: 2025-12-26T00:00:00
first_seen_parent: 2024-02-23
last_seen_parent: 2025-12-26
average_administered: [4.34, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4.3 times with a 5.6 weekly interval (24.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - GASTROENTEROLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2639.63
first_seen: 2024-04-26T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-26
last_seen_parent: 2025-12-31
average_administered: [8.133333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8.1 times with a 6.3 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: 4671.15
first_seen: 2024-02-06T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-30
average_administered: [7.354838709677419, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: arthritis
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.4 times with a 4.4 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - DUPILUMAB
labels: DUPILUMAB
cost_pp_pa: 9358.29
first_seen: 2024-02-12T00:00:00
last_seen: 2025-12-30T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-12-30
average_administered: [4.074074074074074, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.1 times with a 10.6 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma
ids: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - asthma - OMALIZUMAB
labels: OMALIZUMAB
cost_pp_pa: 4951.6
first_seen: 2024-05-15T00:00:00
last_seen: 2025-12-11T00:00:00
first_seen_parent: 2024-05-15
last_seen_parent: 2025-12-11
average_administered: [10.166666666666666, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: asthma
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 10.2 times with a 4.3 weekly interval (44.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - atopic dermatitis
labels: DUPILUMAB
cost_pp_pa: 10232.33
first_seen: 2024-05-10T00:00:00
last_seen: 2025-11-25T00:00:00
first_seen_parent: 2024-05-10
last_seen_parent: 2025-11-25
average_administered: [4.666666666666667, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: atopic dermatitis
drug_sequence: DUPILUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DUPILUMAB</b><br>On average given 4.7 times with a 6.7 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - axial spondyloarthritis
labels: ADALIMUMAB
cost_pp_pa: 1858.81
first_seen: 2024-07-03T00:00:00
last_seen: 2025-12-08T00:00:00
first_seen_parent: 2024-07-03
last_seen_parent: 2025-12-30
average_administered: [6.9375, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: axial spondyloarthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6.9 times with a 7.3 weekly interval (50.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: INFLIXIMAB
cost_pp_pa: 2704.47
first_seen: 2024-04-30T00:00:00
last_seen: 2025-12-24T00:00:00
first_seen_parent: 2024-04-30
last_seen_parent: 2025-12-24
average_administered: [5.153846153846154, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.2 times with a 4.7 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: RITUXIMAB
cost_pp_pa: 1036.29
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-18T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-18
average_administered: [2.6, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 2.6 times with a 14.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: RANIBIZUMAB
cost_pp_pa: 2071.38
first_seen: 2024-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-23
average_administered: [3.946236559139785, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 3.9 times with a 5.7 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - RHEUMATOLOGY (no GP dx)
labels: ETANERCEPT
cost_pp_pa: 4637.58
first_seen: 2024-07-03T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-07-03
last_seen_parent: 2025-12-29
average_administered: [7.833333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: RHEUMATOLOGY (no GP dx)
drug_sequence: ETANERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 7.8 times with a 5.9 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: AFLIBERCEPT
cost_pp_pa: 4770.66
first_seen: 2024-05-07T00:00:00
last_seen: 2025-10-15T00:00:00
first_seen_parent: 2024-05-07
last_seen_parent: 2025-10-31
average_administered: [6.857142857142857, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
ids:
N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx) - AFLIBERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6.9 times with a 5.3 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - OPHTHALMOLOGY (no GP dx)
labels: BEVACIZUMAB
cost_pp_pa: 427.37
first_seen: 2024-08-07T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-08-07
last_seen_parent: 2025-12-31
average_administered: [1.9285714285714286, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: OPHTHALMOLOGY (no GP dx)
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 1.9 times with a 10.3 weekly interval (20.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - breast cancer
labels: BEVACIZUMAB
cost_pp_pa: 608.91
first_seen: 2024-10-16T00:00:00
last_seen: 2025-12-04T00:00:00
first_seen_parent: 2024-10-16
last_seen_parent: 2025-12-04
average_administered: [2.2857142857142856, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: breast cancer
drug_sequence: BEVACIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 2.3 times with a 6.0 weekly interval (14.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: INFLIXIMAB
cost_pp_pa: 4805.19
first_seen: 2024-04-18T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-04-18
last_seen_parent: 2025-12-29
average_administered: [5.9411764705882355, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: INFLIXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5.9 times with a 4.3 weekly interval (25.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: VEDOLIZUMAB
cost_pp_pa: 14440.06
first_seen: 2024-05-09T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-05-09
last_seen_parent: 2025-12-31
average_administered: [6.222222222222222, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6.2 times with a 7.3 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: OMALIZUMAB
cost_pp_pa: 4562.65
first_seen: 2024-02-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-02-15
last_seen_parent: 2025-12-16
average_administered: [9.588235294117647, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: OMALIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>OMALIZUMAB</b><br>On average given 9.6 times with a 4.7 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
labels: ADALIMUMAB
cost_pp_pa: 2281.38
first_seen: 2024-04-15T00:00:00
last_seen: 2025-12-16T00:00:00
first_seen_parent: 2024-04-15
last_seen_parent: 2025-12-16
average_administered: [9.444444444444445, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: GASTROENTEROLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9.4 times with a 7.7 weekly interval (73.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - DERMATOLOGY (no GP dx)
labels: ADALIMUMAB
cost_pp_pa: 2595.68
first_seen: 2024-02-26T00:00:00
last_seen: 2025-12-02T00:00:00
first_seen_parent: 2024-02-26
last_seen_parent: 2025-12-02
average_administered: [5.027027027027027, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: DERMATOLOGY (no GP dx)
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 9.6 weekly interval (48.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: 1755.57
first_seen: 2024-04-17T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-17
last_seen_parent: 2025-12-31
average_administered: [4.928571428571429, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: rheumatoid arthritis
drug_sequence: RITUXIMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4.9 times with a 9.4 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1283.32
first_seen: 2024-02-12T00:00:00
last_seen: 2025-11-20T00:00:00
first_seen_parent: 2024-02-12
last_seen_parent: 2025-11-20
average_administered: [5.0, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: uveitis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5.0 times with a 10.3 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis
ids: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - psoriatic arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: 1035.8
first_seen: 2024-10-07T00:00:00
last_seen: 2025-12-29T00:00:00
first_seen_parent: 2024-10-07
last_seen_parent: 2025-12-29
average_administered: [3.8, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: psoriatic arthritis
drug_sequence: ADALIMUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 3.8 times with a 13.6 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - retinal vein occlusion
labels: DEXAMETHASONE
cost_pp_pa: 5498.52
first_seen: 2024-04-13T00:00:00
last_seen: 2025-12-31T00:00:00
first_seen_parent: 2024-04-13
last_seen_parent: 2025-12-31
average_administered: [1.7826086956521738, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: retinal vein occlusion
drug_sequence: DEXAMETHASONE
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>DEXAMETHASONE</b><br>On average given 1.8 times with a 12.9 weekly interval (23.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: AFLIBERCEPT
cost_pp_pa: 4436.63
first_seen: 2024-02-29T00:00:00
last_seen: 2025-11-21T00:00:00
first_seen_parent: 2024-02-29
last_seen_parent: 2025-12-23
average_administered: [5.583333333333333, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: AFLIBERCEPT
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5.6 times with a 10.0 weekly interval (56.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: N&WICS - NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - macular degeneration
labels: RANIBIZUMAB
cost_pp_pa: 1814.93
first_seen: 2024-02-06T00:00:00
last_seen: 2025-10-07T00:00:00
first_seen_parent: 2024-02-06
last_seen_parent: 2025-12-31
average_administered: [4.476190476190476, NaN, NaN, NaN, NaN, NaN, NaN]
trust_name: NORFOLK AND NORWICH UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
directory: macular degeneration
drug_sequence: RANIBIZUMAB
created_at: 2026-02-06 00:08:55
data_refresh_id: a2c2398c
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4.5 times with a 6.7 weekly interval (30.0 weeks total treatment length)


